Today: 27 June 2026
IPO calendar eyes Bending Spoons as shortened week thins deal pipeline

IPO calendar eyes Bending Spoons as shortened week thins deal pipeline

27 June 2026
Bending Spoons (NASDAQ:BSP) drives 61% of next week’s $2.56 billion U.S. IPO proceeds, making its $1.57 billion raise a key test for investor appetite in debt-heavy software M&A, with a $18.1 billion valuation and 4.0x net debt to EBITDA leverage, as markets brace for a holiday-shortened week and a looming $29.4 billion SK hynix Nasdaq ADR.
Read More
Snowflake (NYSE:SNOW) stock pops 9.7% with trading volume surge

Snowflake (NYSE:SNOW) stock pops 9.7% with trading volume surge

Snowflake soared 9.65% to $248.96 on Friday—adding $7.6 billion in equity value—as investors responded to a 34% jump in product revenue and a 38% surge in remaining performance obligations to $9.21 billion, even as the Nasdaq fell; the stock remains about 11% below the $280 median analyst target after Snowflake raised its annual revenue forecast and AWS deal.
27 June 2026
···
SpaceX (NASDAQ:SPCX) falls after IPO, Russell growth funds left with $73 billion exposure

SpaceX (NASDAQ:SPCX) falls after IPO, Russell growth funds left with $73 billion exposure

SpaceX’s Russell index debut assigns 90.4% of its $80.9 billion notional to growth funds, forcing passive Russell trackers to buy over $4 billion of shares, while the stock trades 32% below its post-IPO high at $153.23; Nasdaq-100 eligibility on July 6 could trigger more index demand, but S&P 500 trackers remain sidelined due to eligibility rules.
27 June 2026
····
Cisco Systems (NASDAQ:CSCO) drop puts AI order wave up against valuation pressures

Cisco Systems (NASDAQ:CSCO) drop puts AI order wave up against valuation pressures

Cisco plunged 4.5% to $113.77, erasing $21 billion in value on heavy volume as FTSE Russell’s reconstitution drove trading; despite the drop, KeyBanc raised its price target to $130, implying 14% upside, but with AI revenue still a small slice of Cisco’s total, investors face pressure to see AI orders convert to revenue amid a volatile tech sector.
26 June 2026
····

June 2026 semiconductor news roundup: U.S. chip controls, SandboxAQ funding and Intel 18A-P

June 2026 semiconductor news roundup: U.S. chip controls, SandboxAQ funding and Intel 18A-P

·····
17 June 2026
U.S. Commerce awarded SandboxAQ $500 million for AI-driven chip materials R&D and took a minority equity stake, while delaying blacklisting over 100 Chinese firms flagged as security risks, highlighting Washington’s focus on domestic chip supply chains and export controls as Intel’s 18A-P enters risk production and AI-chip startups challenge Nvidia’s dominance.
Read More
June 2025 AI News Roundup: Breakthroughs, Surprises, and Global Developments

June 2025 AI News Roundup: Breakthroughs, Surprises, and Global Developments

······
28 June 2025
OpenAI CEO Sam Altman said GPT-5 will launch in summer 2025, claiming major improvements over GPT-4. Midjourney released its first text-to-video system, Model V1, in June 2025. Meta delayed LLaMA 4 Behemoth to late 2025 due to performance issues. Google DeepMind introduced Gemini Robotics On-Device, running vision-language-action AI entirely on robots.
Read More

Latest

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

GameStop surged 3.57% to $21.76 and jumped after hours as it forecast FY2026 adjusted EBITDA above $600 million, nearly doubling from 2025; with a $9.76 billion market cap now close to its $9.7 billion in cash, securities, digital assets, and collateral, investors are weighing whether GameStop’s cash-rich balance sheet can support equity while Ryan Cohen pursues an eBay bid.
···
27 Jun
Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid surged 15.6% Friday, adding $312 million in equity value—almost double the $158 million in annualized savings from this week’s restructuring plan that cut 18% of its U.S. workforce. Friday’s volume equaled 54% of reported short interest, but the rally outpaced cost-cutting fundamentals, leaving less room for further gains based solely on headcount cuts.
··
27 Jun
Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

Moderna soared 12.6% Friday on heavy volume after unveiling new in vivo CAR-T pipeline plans, closing at $67.27—52% above the mean analyst target but still 14.5% below Piper Sandler’s new $77 target. The rally followed Science Day updates, even as analysts note the main new asset is preclinical and cash burn continues, with $7.5B cash at March-end and a projected $3B R&D spend for 2026.
··
27 Jun
IPO calendar eyes Bending Spoons as shortened week thins deal pipeline

IPO calendar eyes Bending Spoons as shortened week thins deal pipeline

Bending Spoons (NASDAQ:BSP) drives 61% of next week’s $2.56 billion U.S. IPO proceeds, making its $1.57 billion raise a key test for investor appetite in debt-heavy software M&A, with a $18.1 billion valuation and 4.0x net debt to EBITDA leverage, as markets brace for a holiday-shortened week and a looming $29.4 billion SK hynix Nasdaq ADR.
··········
27 Jun
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 27.06.2026

LIVEMarkets rolling coverageStarted: June 27, 2026, 4:00 AM EDTUpdated: June 27, 2026, 11:26 AM EDT Telix Pharmaceuticals and Two Australian Insider-Led Growth Stocks Highlighted June 27, 2026, 11:07 AM EDT. Telix Pharmaceuticals (ASX:TLX), a A$5.2 billion biopharmaceutical firm specializing in radiopharmaceuticals for cancer imaging and treatment, draws growth-focused investors despite ongoing losses. The company reported US$621.9 million revenue from Precision Medicine and relies heavily on its oncology pipeline with products like Illuccix and late-stage candidates TLX591 and TLX101. Key risks include high R&D costs, regulatory scrutiny, pricing pressures, and trial dependencies. Also featured are two Australian insider-led growth stocks identified
·
27 Jun
US futures edge lower ahead of Russell index reshuffle as chip stocks see selling

US stocks: After-hours chips slump overshadows gains ahead of jobs data

PHLX chip index plunged 5.3% Friday and 7.9% for the week as surging memory costs hit device makers like Apple, driving $20 billion in tech fund outflows and raising inflation fears, while S&P 500 advancers outnumbered decliners and after-hours trading showed no clear tech rebound.
·············
27 Jun
Go toTop